A multicenter, randomized, comparative trial on the effect of febuxostat in preventing cerebral and cardiorenovascular events in patients with hyperuricemia

Trial Profile

A multicenter, randomized, comparative trial on the effect of febuxostat in preventing cerebral and cardiorenovascular events in patients with hyperuricemia

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2016

At a glance

  • Drugs Febuxostat (Primary) ; Allopurinol
  • Indications Cardiovascular disorders; Cerebrovascular disorders; Hyperuricaemia; Kidney disorders
  • Focus Therapeutic Use
  • Acronyms FREED
  • Most Recent Events

    • 04 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 01 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top